Matrix Labs Receives U.S. FDA Approval for Kazipally Facility

Matrix Laboratories Ltd has received U.S. FDA approval for its Active Pharmaceutical Ingredients (APIs) manufacturing facility located at Kazipally (Unit-II), near Hyderabad. The facility currently manufactures antiretrovirals (ARVs) for the treatment of HIV/AIDS. The approval will enable the company to supply ARV APIs to President Bush's $15 billion PEPFAR (The President's Emergency Plan for AIDS Relief) program, besides other regulated markets.

myiris (http://www.myiris.com/newsCentre/newsPopup.php?fileR=20050419170115002&dir=2005/04/19&secID=livenews)